Inhibition of Tumor Growth by Targeted Anti-EGFR/IGF-1R Nanobullets Depends on Efficient Blocking of Cell Survival Pathways
Roy van der Meel(Eindhoven University of Technology), Raymond M. Schiffelers(University Medical Center Utrecht), Wim E. Hennink(Utrecht University), Raimond Heukers(Utrecht University), Gert Storm(Yong In University), Ebel H. E. Pieters(Utrecht University), Işıl Altıntaş(Genmab (Netherlands)), Robbert J. Kok(Utrecht University), Sabrina Oliveira(Unknown), Paul M.P. van Bergen en Henegouwen(Utrecht University)
Cited by 37
Related Papers
The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs
|Nature Nanotechnology|2019|1.6k
The current landscape of nucleic acid therapeutics
|Nature Nanotechnology|2021|1.3k
Smart cancer nanomedicine
|Nature Nanotechnology|2019|1.2k